Increased oro-cecal transit time in grade I or II hepatic encephalopathy

被引:12
作者
Bouin, M [1 ]
Vincent, C [1 ]
Bouhier, K [1 ]
Debruyne, D [1 ]
Fatome, A [1 ]
Piquet, MA [1 ]
Verwaerde, JC [1 ]
Dao, T [1 ]
机构
[1] CHU Cote Nacre, Serv Hepatogastroenterol, F-14033 Caen, France
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2004年 / 28卷 / 12期
关键词
D O I
10.1016/S0399-8320(04)95217-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The pathogenic mechanisms of hepatic encephalopathy remain to be elucidated. It has been suggested that a digestive motor disorder could promote the absorption of toxins produced within the lumen and thus enhance hepatic encephalopathy. Aim - To evaluate oro-cecal transit time in cirrhotic patients with and without hepatic encephalopathy. Methods - Hospitalized patients with alcoholic cirrhosis without encephalopathy and with spontaneous grade I and II encephalopathy were included. Severity of hepatic encephalopothy was assessed clinically and the Child-Pugh score was used to describe cirrhosis severity. Nine healthy volunteers constituted a control group. Oro-cecal transit time was measured with the sulfasalazine test. Results - Twenty-eight patients (mean age 62.5 +/- 8.5 years) were included. Ten had hepatic encephalopathy of unknown cause and 18 were free of hepatic encephalopathy. Oro-cecal transit time was significantly longer in patients with hepatic encephalopathy (641 +/- 350 min) compared to patients without hepatic encephalopathy (298 +/- 96; P < 0.05) and to controls (354 +/- 90; P < 0.05). Oro-cecal transit time was comparable for each Child-Pugh score and was not different between the two grades of hepatic encephalopathy. Conclusion - Oro-cecal transit time is longer in alcoholic cirrhosis patients with hepatic encephalopathy. This digestive motor disorder provides a partial explanation of hepatic encephalopathy of unknown etiology.
引用
收藏
页码:1240 / 1244
页数:5
相关论文
共 28 条
  • [1] BENHAMOU J, 1993, HEPATOLOGIE CLIN
  • [2] MONOAMINES AND METABOLITES IN AUTOPSIED BRAIN-TISSUE FROM CIRRHOTIC-PATIENTS WITH HEPATIC-ENCEPHALOPATHY
    BERGERON, M
    READER, TA
    LAYRARGUES, GP
    BUTTERWORTH, RF
    [J]. NEUROCHEMICAL RESEARCH, 1989, 14 (09) : 853 - 859
  • [3] SIMULTANEOUS NONINVASIVE EVALUATION OF GASTRIC-EMPTYING AND OROCECAL TRANSIT TIMES - USE IN STUDYING THE ACTIONS OF CISAPRIDE IN DIABETIC-PATIENTS
    BERGMANN, JF
    CHASSANY, O
    GUILLAUSSEAU, PJ
    BAYLE, M
    CHAGNON, S
    CAULIN, C
    SALLENAVE, JR
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) : 121 - 124
  • [4] BOUIN M, 1997, GASTROENTEROL CLIN B, V21, P194
  • [5] PATHOGENESIS AND TREATMENT OF PORTAL SYSTEMIC ENCEPHALOPATHY - AN UPDATE
    BUTTERWORTH, RF
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (03) : 321 - 327
  • [6] The impact of chronic hepatitis B viral infection on gastrointestinal motility
    Chen, CY
    Lu, CL
    Chang, FY
    Huang, YS
    Lee, FY
    Lu, RH
    Kang, LJ
    Lee, SD
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (09) : 995 - 1000
  • [7] CHESTA J, 1993, HEPATOLOGY, V17, P828, DOI 10.1016/0270-9139(93)90159-K
  • [8] CONN HO, 1978, HEPATIC COMA SYNDROM, P46
  • [9] CLINICAL PHARMACOKINETICS OF SULFASALAZINE
    DAS, KM
    DUBIN, R
    [J]. CLINICAL PHARMACOKINETICS, 1976, 1 (06) : 406 - 425
  • [10] DUCROTTE P, 1992, THERAPIE, V47, P111